The latest closing stock price for Gain Therapeutics as of May 30, 2025 is 1.77.
An investor who bought $1,000 worth of Gain Therapeutics stock at the IPO in 2021 would have $-842 today, roughly -1 times their original investment - a -36.95% compound annual growth rate over 4 years.
The all-time high Gain Therapeutics stock closing price was 15.80 on April 05, 2021.
The Gain Therapeutics 52-week high stock price is 3.19, which is 80.2% above the current share price.
The Gain Therapeutics 52-week low stock price is 0.89, which is 49.7% below the current share price.
The average Gain Therapeutics stock price for the last 52 weeks is 1.82.
An investor who bought $1,000 worth of Gain Therapeutics stock at the IPO in 2021 would have $-842 today, roughly -1 times their original investment - a -36.95% compound annual growth rate over 4 years.
The all-time high Gain Therapeutics stock closing price was 15.80 on April 05, 2021.
The Gain Therapeutics 52-week high stock price is 3.19, which is 80.2% above the current share price.
The Gain Therapeutics 52-week low stock price is 0.89, which is 49.7% below the current share price.
The average Gain Therapeutics stock price for the last 52 weeks is 1.82.